166 related articles for article (PubMed ID: 33068445)
1. Different injection patterns of incobotulinumtoxinA for crow's feet: a split-face comparative study.
Vachiramon V; Subpayasarn U; Triyangkulsri K; Jurairattanaporn N; Rattananukrom T
J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):256-262. PubMed ID: 33068445
[TBL] [Abstract][Full Text] [Related]
2. A Prospective, Neurophysiologic Comparative Study to Assess the Efficacy and Duration of Effect of IncobotulinumtoxinA and AbobotulinumtoxinA in the Treatment of Crow's Feet.
Saybel A; Artemenko A; Nikitin S; Kurenkov A
J Drugs Dermatol; 2015 Nov; 14(11):1291-6. PubMed ID: 26580879
[TBL] [Abstract][Full Text] [Related]
3. A Comparative
Cao Y; Yang JP; Zhu XG; Zhu J; Chang HQ; Guo SH; Luo D; Zhou BR
Biomed Res Int; 2018; 2018():6235742. PubMed ID: 30057908
[TBL] [Abstract][Full Text] [Related]
4. Clinical Evaluation of a Topical Unani Polyherbal Formulation in the Management of Photodamaged Facial skin: An open-label Standard Controlled Trial.
Bibi C; Nigar Z
Altern Ther Health Med; 2024 Mar; 30(3):16-23. PubMed ID: 38518171
[TBL] [Abstract][Full Text] [Related]
5. A prospective rater- and subject-blinded study comparing the efficacy of incobotulinumtoxinA and onabotulinumtoxinA to treat crow's feet: a clinical crossover evaluation.
Muti G; Harrington L
Dermatol Surg; 2015 Jan; 41 Suppl 1():S39-46. PubMed ID: 25548844
[TBL] [Abstract][Full Text] [Related]
6. Assessment of efficacy of platelet-rich plasma (PRP) on infraorbital dark circles and crow's feet wrinkles.
Mehryan P; Zartab H; Rajabi A; Pazhoohi N; Firooz A
J Cosmet Dermatol; 2014 Mar; 13(1):72-8. PubMed ID: 24641609
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Prabotulinumtoxin A and Onabotulinumtoxin A for Crow's Feet: A Phase 3, Multicenter, Randomized, Double-Blind, Split-Face Study.
Cheon HI; Jung N; Won CH; Kim BJ; Lee YW
Dermatol Surg; 2019 Dec; 45(12):1610-1619. PubMed ID: 30893169
[TBL] [Abstract][Full Text] [Related]
8. A randomized, patient/evaluator-blinded, split-face study to compare the efficacy and safety of polycaprolactone and polynucleotide fillers in the correction of crow's feet: The latest biostimulatory dermal filler for crow's feet.
Jeong GJ; Ahn GR; Park SJ; Hong JY; Kim BJ
J Cosmet Dermatol; 2020 Jul; 19(7):1593-1599. PubMed ID: 31680395
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous crow's feet line patterns and customized botulinum toxin rejuvenating treatment.
Cavallini M; Papagni M; Augelli F; Muti GF; Santorelli A; Raichi M
J Cosmet Dermatol; 2022 Oct; 21(10):4294-4300. PubMed ID: 35723939
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid microneedle patch for the improvement of crow's feet wrinkles.
Choi SY; Kwon HJ; Ahn GR; Ko EJ; Yoo KH; Kim BJ; Lee C; Kim D
Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28892233
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Clinical Efficacy of Abobotulinumtoxin A (ABO) and Onabotulinumtoxin A (ONA) in the Treatment of Crow's Feet Wrinkles: A Split-Face Study.
Elridy AS; Zaki RGE; Elshinawy RF
Semin Ophthalmol; 2018; 33(6):739-747. PubMed ID: 29278961
[TBL] [Abstract][Full Text] [Related]
12. Ultrasonographic analyses of Crow's feet and novel guideline for botulinum toxin injection.
Piao JZ; Oh W; Choi YJ; Lee JH; Bae H; Hu KS; Kim HM; Kim HJ
J Cosmet Dermatol; 2022 Sep; 21(9):3787-3793. PubMed ID: 35716350
[TBL] [Abstract][Full Text] [Related]
13. Effects of Polynucleotide Dermal Filler in the Correction of Crow's Feet Using an Antera Three-Dimensional Camera.
Kim JH; Kim ES; Kim SW; Hong SP; Kim J
Aesthetic Plast Surg; 2022 Aug; 46(4):1902-1909. PubMed ID: 35357558
[TBL] [Abstract][Full Text] [Related]
14. A Prospective, Split-Face, Randomized, Double-Blind Study Comparing OnabotulinumtoxinA to IncobotulinumtoxinA for Upper Face Wrinkles.
Yeilding RH; Fezza JP
Plast Reconstr Surg; 2015 May; 135(5):1328-1335. PubMed ID: 25919246
[TBL] [Abstract][Full Text] [Related]
15. Static Crow's Feet Treated with Voltaic Arc Dermabrasion (Atmospheric Plasma): Post-Operative Pain Assessment by Thermal Infrared Imaging.
Scarano A; Inchingolo F; Amuso D; Scogna G; Amore R; Lorusso F
J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300242
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the Efficacy and Durability of IncobotulinumtoxinA in the Treatment of the Upper Face in Adult Women.
de Almeida AT; de Sanctis Pecora C; Marques ER; Contin L; de Almeida CT; da Cunha AL
Dermatol Ther (Heidelb); 2024 Jul; ():. PubMed ID: 38954382
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Lateral Periorbital Lines with Different Dilutions of IncobotulinumtoxinA.
Muti GF; Basso M
J Clin Aesthet Dermatol; 2017 Sep; 10(9):27-29. PubMed ID: 29344324
[No Abstract] [Full Text] [Related]
18. Introduction of the Microdroplet Technique with Incobotulinumtoxin A for the Treatment of Crow's Feet.
Imhof M; Kuhne U
J Clin Aesthet Dermatol; 2013 Jul; 6(7):40-4. PubMed ID: 23882314
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
Ascher B; Rzany BJ; Grover R
Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative injection of botulinum toxin A into orbicularis oculi muscle for the treatment of crow's feet.
Guerrissi JO
Plast Reconstr Surg; 2000 May; 105(6):2219-25; discussion 2226-8. PubMed ID: 10839423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]